RecruitingNot ApplicableNCT04652609
Preventing Chemotherapy-induced Peripheral Neuropathy Using PRESIONA Exercise Program
Prevention of Chemotherapy-induced Peripheral Neuropathy With Therapeutic Exercise and Blood Flow Restriction Using PRESIONA Program
Sponsor
Universidad de Granada
Enrollment
25 participants
Start Date
Jan 1, 2021
Study Type
INTERVENTIONAL
Conditions
Summary
The aim of this study is to determinate if therapeutic exercise with blood flow restriction (BFR) during neoadjuvant chemotherapy potentialy neurotoxic could prevent the onset of chemotherapy induced peripheral neuropathy (CIPN) comparing to usual care.
Eligibility
Sex: FEMALEMin Age: 18 YearsMax Age: 70 Years
Inclusion Criteria3
- years or older
- HER2+ breast cancer diagnosis
- On the waiting list to anticancer medical treatment (taxanes-based neoadjuvant chemotherapy)
Exclusion Criteria5
- Previous diagnosis of cancer
- Pregnant
- Cardiac pathology
- No symptoms or pathology that could be confused with neuropathy or related to diabetes
- No recommendation from oncologist for therapeutic exercise practice
Interventions
OTHERPRESIONA
Aerobic and strength exercise combined with restricction blood flow cuffs during chemotherapy treatment
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04652609
Related Trials
Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy
NCT062686651 location
Cryoablation vs Lumpectomy in T1 Breast Cancers
NCT055056431 location
Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring
NCT047995351 location
A Prospective Study to Develop and Clinically Validate an in Vitro Diagnostic Medical Device That Uses Blood to Classify Patients at High Risk for Breast Cancer
NCT066723022 locations
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
NCT0607261277 locations